北京商报讯(记者丁宁)5月7日晚间,百济神州(688235)发布2025年第一季度主要财务数据公告显示,报告期内,公司实现营业收入80.48亿元,同比增长50.2%;归属净利润为-9450.3万元,上年同期为-19.08亿元,同比大幅减亏。 百济神州表示,第一季度营业收入较上年同期增加50.2%,主要得益于公司自研产品百悦泽(泽布替尼胶囊),以及百泽安(替雷利珠单抗)和安进授权产品的销售增长。(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.